Partial breast re-irradiation for cancer recurrence
Part of Cancer, Skin clinical trials.
This trial tests a shorter course of radiation to only the part of the breast where cancer has come back. It's for women who had radiation years ago and now have a small new or recurrent tumor that can be removed by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18.
- You have a new or returning breast cancer (either non-invasive or invasive) that is smaller than 3 cm.
- It has been more than 5 years since you finished your last radiation treatment to the breast.
- The cancer has not spread to your lymph nodes or other parts of your body.
- Your tumor was completely removed with clear margins (no cancer cells at the edge).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a personalized plan to remove and re-treat a limited breast recurrence while trying to keep the breast. It may help people whose cancer came back in the same breast after prior breast-conserving treatment, with certain size and spread limits.
This trial tests whether a shorter, 3-day course of partial breast radiation after surgery works as well as standard radiation for women with early-stage breast cancer. It may help reduce time in treatment while aiming to keep cancer from coming back in the treated breast area.
This Phase 2 study tests whether giving targeted radiation again to the same breast can control a small, local breast cancer that came back after prior whole-breast radiation. It may help some patients avoid or delay further treatment for the breast while carefully checking safety.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a second, shorter course of radiation to just the area where your cancer was removed, instead of treating the whole breast again. It is for women who have had a new breast cancer in the same breast after previous radiation, to see if this approach is safe and effective.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.